The foundation laid through field isolations in 2010-2013 was strengthened in 2020 by Antarctic sampling under the TÜBİTAK 1001 program, which strengthened the ASYA culture collection. From 2022 onward, deepening work on UV-protective biomolecules, biostimulants, and phycobiliproteins extended into space biotechnology in 2023 through the UZMAN project. In 2024, TAES was founded with support from TÜBİTAK 1812, and- via the KOSGEB program- production infrastructure, quality systems, and end-to-end traceability were commissioned. We are now advancing through extended testing and pre-manufacturing toward pilot batches and field validations in 2025, followed by the commercialization of safe, compliant, market-ready product families.